SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 15.16 |
Enterprise Value ($M) | -0.87 |
Book Value ($M) | 105.53 |
Book Value / Share | 1.10 |
Price / Book | 0.14 |
NCAV ($M) | -1.16 |
NCAV / Share | -0.01 |
Price / NCAV | -13.03 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.01 |
Return on Assets (ROA) | -0.65 |
Return on Equity (ROE) | -0.71 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.78 |
Current Ratio | 2.53 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 47.77 |
Assets | 154.46 |
Liabilities | 48.93 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.77 |
Operating Income | -118.38 |
Net Income | -116.66 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -102.00 |
Cash from Investing | -29.07 |
Cash from Financing | 36.52 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Alyeska Investment Group, L.P. | 9.99 | ||
13G | Armistice Capital, Llc | 6.71 | ||
13G/A | Tang Capital Partners Lp | 0.00 | ||
13G | Empery Asset Management, LP | 9.99 | ||
13G | Sabby Management, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
340,072 | 901,733 | 37.71 | |
422,806 | 102,988 | 410.54 | |
441,778 | 95,758 | 461.35 | |
374,513 | 110,472 | 339.01 | |
(click for more detail) |
Similar Companies | |
---|---|
THTX – Theratechnologies Inc. | TIL – Instil Bio, Inc. |
TLSA – Tiziana Life Sciences Ltd | TPST – Tempest Therapeutics, Inc. |
TRAW – Traws Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io